GB0820965D0 - Suppression of cancers - Google Patents

Suppression of cancers

Info

Publication number
GB0820965D0
GB0820965D0 GB0820965A GB0820965A GB0820965D0 GB 0820965 D0 GB0820965 D0 GB 0820965D0 GB 0820965 A GB0820965 A GB 0820965A GB 0820965 A GB0820965 A GB 0820965A GB 0820965 D0 GB0820965 D0 GB 0820965D0
Authority
GB
United Kingdom
Prior art keywords
cancers
suppression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0820965A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntaxin Ltd
Original Assignee
Syntaxin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntaxin Ltd filed Critical Syntaxin Ltd
Priority to GB0820965A priority Critical patent/GB0820965D0/en
Publication of GB0820965D0 publication Critical patent/GB0820965D0/en
Priority to AU2009259034A priority patent/AU2009259034B2/en
Priority to CA2727082A priority patent/CA2727082C/en
Priority to JP2011513056A priority patent/JP5728380B2/en
Priority to ES13179177T priority patent/ES2750651T3/en
Priority to EP19175007.4A priority patent/EP3590956A1/en
Priority to EP09762018.1A priority patent/EP2310028B1/en
Priority to PCT/GB2009/050666 priority patent/WO2009150470A2/en
Priority to EP18199184.5A priority patent/EP3473643A1/en
Priority to EP13179177.4A priority patent/EP2719392B1/en
Priority to EP09762019.9A priority patent/EP2310029B1/en
Priority to US12/996,641 priority patent/US10240138B2/en
Priority to CN201710541016.7A priority patent/CN107446053A/en
Priority to ES09762018.1T priority patent/ES2614990T3/en
Priority to BRC10915888A priority patent/BRPI0915888E2/en
Priority to PCT/GB2009/050665 priority patent/WO2009150469A2/en
Priority to CN201410295607.7A priority patent/CN104328100B/en
Priority to AU2009259033A priority patent/AU2009259033B2/en
Priority to US12/996,643 priority patent/US20110171191A1/en
Priority to CN200980130069.3A priority patent/CN102112145B/en
Priority to CA2726092A priority patent/CA2726092A1/en
Priority to CN2009801220928A priority patent/CN102083451A/en
Priority to KR1020117000251A priority patent/KR101642363B1/en
Priority to ES09762019T priority patent/ES2732205T3/en
Priority to JP2011513057A priority patent/JP5799397B2/en
Priority to BRPI0915142A priority patent/BRPI0915142A8/en
Priority to KR1020117000258A priority patent/KR101731655B1/en
Priority to ZA2010/08425A priority patent/ZA201008425B/en
Priority to ZA2010/08536A priority patent/ZA201008536B/en
Priority to IL209854A priority patent/IL209854A/en
Priority to IL209855A priority patent/IL209855A/en
Priority to US12/969,810 priority patent/US8796216B2/en
Priority to US12/969,826 priority patent/US20110158973A1/en
Priority to US14/250,959 priority patent/US20140302006A1/en
Priority to US14/250,954 priority patent/US10550377B2/en
Priority to JP2014087047A priority patent/JP5891258B2/en
Priority to HK18106227.2A priority patent/HK1246809A1/en
Ceased legal-status Critical Current

Links

GB0820965A 2008-06-12 2008-11-17 Suppression of cancers Ceased GB0820965D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GB0820965A GB0820965D0 (en) 2008-11-17 2008-11-17 Suppression of cancers
CA2727082A CA2727082C (en) 2008-06-12 2009-06-11 Fusion proteins for use in suppression of acromegaly
US12/996,643 US20110171191A1 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
CA2726092A CA2726092A1 (en) 2008-06-12 2009-06-11 Suppression of cancers
JP2011513056A JP5728380B2 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine disease
CN200980130069.3A CN102112145B (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
EP19175007.4A EP3590956A1 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
EP09762018.1A EP2310028B1 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of acromegaly
PCT/GB2009/050666 WO2009150470A2 (en) 2008-06-12 2009-06-11 Suppression of cancers
EP18199184.5A EP3473643A1 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatemnt of cancer
EP13179177.4A EP2719392B1 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of acromegaly
EP09762019.9A EP2310029B1 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of cancer
US12/996,641 US10240138B2 (en) 2008-06-12 2009-06-11 Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
CN201710541016.7A CN107446053A (en) 2008-06-12 2009-06-11 The suppression of cancer
ES09762018.1T ES2614990T3 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of acromegaly
BRC10915888A BRPI0915888E2 (en) 2008-06-12 2009-06-11 polypeptide, its activation method, nucleic acid sequence encoding it and its use
PCT/GB2009/050665 WO2009150469A2 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
CN201410295607.7A CN104328100B (en) 2008-06-12 2009-06-11 The inhibition of neuroendocrine disease
AU2009259033A AU2009259033B2 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
AU2009259034A AU2009259034B2 (en) 2008-06-12 2009-06-11 Suppression of cancers
ES13179177T ES2750651T3 (en) 2008-06-12 2009-06-11 Fusion proteins for use in the treatment of acromegaly
KR1020117000258A KR101731655B1 (en) 2008-06-12 2009-06-11 Suppression of cancers
KR1020117000251A KR101642363B1 (en) 2008-06-12 2009-06-11 Suppression of neuroendocrine diseases
CN2009801220928A CN102083451A (en) 2008-06-12 2009-06-11 Suppression of cancers
ES09762019T ES2732205T3 (en) 2008-06-12 2009-06-11 Fusion proteins for use in cancer treatment
JP2011513057A JP5799397B2 (en) 2008-06-12 2009-06-11 Cancer suppression
BRPI0915142A BRPI0915142A8 (en) 2008-06-12 2009-06-11 POLYPEPTIDES, NUCLEIC ACID AND USES THEREOF
ZA2010/08425A ZA201008425B (en) 2008-06-12 2010-11-24 Suppression of cancers
ZA2010/08536A ZA201008536B (en) 2008-06-12 2010-11-29 Suppression of neuroendocrine diseases
IL209854A IL209854A (en) 2008-06-12 2010-12-08 Polypeptide, nucleic acid sequence encoding such a polypeptide and the use of such a polypeptide in the preparation of a medicament for suppressing cancer
IL209855A IL209855A (en) 2008-06-12 2010-12-08 Polypeptide, nucleic acid sequence encoding such a polypeptide and the use of such a polypeptide in the preparation of a medicament for treating acromegaly
US12/969,810 US8796216B2 (en) 2008-06-12 2010-12-16 Suppression of neuroendocrine diseases
US12/969,826 US20110158973A1 (en) 2008-06-12 2010-12-16 Suppression of cancers
US14/250,959 US20140302006A1 (en) 2008-06-12 2014-04-11 Suppression of neuroendocrine diseases
US14/250,954 US10550377B2 (en) 2008-06-12 2014-04-11 Suppression of prostate cancer using a targeted clostridial neurotoxin
JP2014087047A JP5891258B2 (en) 2008-06-12 2014-04-21 Suppression of neuroendocrine disease
HK18106227.2A HK1246809A1 (en) 2008-06-12 2018-05-14 Suppression of cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0820965A GB0820965D0 (en) 2008-11-17 2008-11-17 Suppression of cancers

Publications (1)

Publication Number Publication Date
GB0820965D0 true GB0820965D0 (en) 2008-12-24

Family

ID=40194725

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0820965A Ceased GB0820965D0 (en) 2008-06-12 2008-11-17 Suppression of cancers

Country Status (1)

Country Link
GB (1) GB0820965D0 (en)

Similar Documents

Publication Publication Date Title
HK1246809A1 (en) Suppression of cancers
HK1245114A1 (en) Suppression of cancer
GB0920732D0 (en) Noise suppression
GB2459968B (en) Efficiency-based determination of operational characteristics
ZA201008536B (en) Suppression of neuroendocrine diseases
GB0818498D0 (en) Provision of inserts
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
PL2133419T3 (en) Uses of cyanophycin beta-dipeptides
GB0817047D0 (en) Electromagnetic Interference Suppression
GB0806926D0 (en) Determination of particle properties
PL2328545T3 (en) Use of glucosylglycerol
GB0820309D0 (en) Detection of cancer
HK1160925A1 (en) Use of athepsin
IL219898A0 (en) Suppression of cancer metastasis
PL2473549T3 (en) Synthesis of fluorocarbofunctional silsesquioxanes
EP2331490A4 (en) Preparation of dibutoxymethane
GB0820965D0 (en) Suppression of cancers
GB0810782D0 (en) Suppression of cancers
TWM372743U (en) Improved structure of Kendama
TWM365675U (en) Improved structure of teapoy
GB0811560D0 (en) Suppression of hypertension
GB0910052D0 (en) Suppression of hypertension
PL386303A1 (en) New derivative of pyrrolopyridazine
PL386965A1 (en) New derivative of pyrrolopyridazine
PL386968A1 (en) New derivative of pyrrolopyridazine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)